GlaxoSmithKline has agreed to pay $3 billion to resolve federal investigations into the marketing of some of its drugs, including the controversial type 2 diabetes drug, Avandia. According to a report from Bloomberg News, the agreement with the U.S. Department of Justice would constitute Glaxo’s biggest legal settlement so far. Negotiations to finalize [...]

• The Construction & Operation of Clandestine Drug Laboratories
  

  The Construction & Operation of Clandestine Drug Laborato...

  The Construction & Operation of Clandestine Drug Laboratories drug design – click on the image...

  Read Full Story »
• California Avandia Lawyers
  

  California Avandia Lawyers

  The first sign of serious side effects was admitted by GlaxoSmithKline way back in...

  Read Full Story »
• Avandia is a type2 anti-diabetic drug
  

  Avandia is a type2 anti-diabetic drug

  Article by Mike Bordon Avandia is used as an anti-diabetic medication...

  Read Full Story »
• I want to know what is in the drug that the FDA recalled it is called DIGITEC or digoxin?
  

  I want to know what is in the drug that the FDA recalled ...

  by Coal and Ice I want to know what is in the drug that the FDA re called it is called DIGITEC...

  Read Full Story »
• GlaxoSmithKline settles U.S. drug rows for $3 billion
  GlaxoSmithKline settles U.S. drug rows for $3 billion

  LONDON ( Reuters ) - GlaxoSmithKline Plc has agreed in principle to settle several long-standing disputes with the U.S. government over the way it marketed and developed drugs, at a cost of $3...

  Read Full Story »